AT ANTIPSYCHOTIC-LIKE EFFECTIVE DOSES, CARIPRAZINE DISPLAYS POTENT DOPAMINE D3 AND D2 RECEPTOR OCCUPANCY IN VIVO AND EFFICACY ACROSS ANIMAL MODELS

被引：0
|
作者：
Adham, N. [1 ]
Gyertyn, I. [2 ]
Laszlovszky, I. [3 ]
Kiss, B. [4 ]
机构：
[1] Forest Res Inst, Jersey City, NJ USA
[2] Gedeon Richter Plc, Behav Pharmacol, Budapest, Hungary
[3] Gedeon Richter Plc, Med Div, Budapest, Hungary
[4] Gedeon Richter Plc, Pharmacol & Safety Res, Budapest, Hungary
来源：
EUROPEAN PSYCHIATRY | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPA-0579
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cariprazine, a D3/D2 Dopamine Receptor Partial Agonist Antipsychotic, Displays Greater D3 Receptor Occupancy In Vivo Compared with Other Antipsychotics
    Kiss, Bela
    Horti, Ferenc
    Bobok, Amrita
    Adham, Nika
    [J]. BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 40S - 40S
  • [2] CARIPRAZINE, A D3/D2 DOPAMINE RECEPTOR PARTIAL AGONIST ANTIPSYCHOTIC, DISPLAYS GREATER D3 RECEPTOR OCCUPANCY IN VIVO COMPARED WITH OTHER ANTIPSYCHOTICS
    Kiss, Bela
    Horti, Ferenc
    Bobok, Amrita
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 136 : S190 - S190
  • [3] Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents
    Gyertyan, Istvan
    Kiss, Bela
    Saghy, Katalin
    Laszy, Judit
    Szabo, Gyoergyi
    Szabados, Tamas
    Gemesi, Larisza I.
    Pasztor, Gabriella
    Zajer-Balazs, Maria
    Kapas, Margit
    Csongor, Eva Agai
    Domany, Gyoergy
    Tihanyi, Karoly
    Szombathelyi, Zsolt
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2011, 59 (06) : 925 - 935
  • [4] DOPAMINE D2 AND D3 RECEPTOR OCCUPANCY OF CARIPRAZINE IN SCHIZOPHRENIC PATIENTS
    Keator, David B.
    Mukherjee, J.
    Preda, A.
    Highum, D.
    Lakatos, A.
    Gage, A.
    Potkin, S. G.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 154 - 154
  • [5] Dopamine D3 and D2 receptor occupancy of cariprazine in schizophrenic patients
    Potkin, S.
    Keator, D.
    Mukherjee, J.
    Preda, A.
    Highum, D.
    Gage, A.
    Xie, J.
    Ghahramani, P.
    Laszlovsky, I.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S316 - S316
  • [6] In Vivo Dopamine D3 and D2 Receptor Occupancy Profile of Cariprazine Versus Aripiprazole: A PET Study
    Girgis, Ragy
    Abi-Dargham, Anissa
    Slifstein, Mark
    Chen, Laishun
    Periclou, Antonia
    Adham, Nika
    Earley, Willie
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S595 - S596
  • [7] Adjunctive treatment with topiramate augments the antipsychotic-like efficacy of dopamine D2 receptor blockage
    Eltayb, A
    Wadenberg, ML
    Schilström, B
    Mamerfelt, A
    Svensson, TH
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2004, 58 (02) : 93 - 94
  • [8] Cariprazine (RGH-188), a Potential Antipsychotic with Dopamine D3/D2 Functional Antagonist Properties, Attenuates Manic-Like Behaviors in Animal Models
    Adham, Nika
    Samoriski, Gary
    Gao, Yonglin
    Hougland, Tyler
    Lei, Zhenmin
    El-Mallakh, Rif S.
    Kiss, Bela
    Szombathelyi, Zsolt
    Gyertyan, Istvan
    [J]. BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 205S - 206S
  • [9] Antipsychotic-Like Efficacy of Dopamine D2 Receptor-Biased Ligands is Dependent on Adenosine A2A Receptor Expression
    Sahlholm, Kristoffer
    Gomez-Soler, Maricel
    Valle-Leon, Marta
    Lopez-Cano, Marc
    Taura, Jaume J.
    Ciruela, Francisco
    Fernandez-Duenas, Victor
    [J]. MOLECULAR NEUROBIOLOGY, 2018, 55 (06) : 4952 - 4958
  • [10] Antipsychotic-Like Efficacy of Dopamine D2 Receptor-Biased Ligands is Dependent on Adenosine A2A Receptor Expression
    Kristoffer Sahlholm
    Maricel Gómez-Soler
    Marta Valle-León
    Marc López-Cano
    Jaume J. Taura
    Francisco Ciruela
    Víctor Fernández-Dueñas
    [J]. Molecular Neurobiology, 2018, 55 : 4952 - 4958
12345